Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 20Hodgkin Disease 19Myelodysplastic Syndromes 18Lymphoma, Non-Hodgkin 16Myeloproliferative Disorders 14Lymphoma, Mantle-Cell 14Leukemia, Myelomonocytic, Chronic 14Multiple Myeloma 13Lymphoma, Large B-Cell, Diffuse 12Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Prolymphocytic 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Lymphoma 8Burkitt Lymphoma 8Anemia, Refractory, with Excess of Blasts 8Myelodysplastic-Myeloproliferative Diseases 7Leukemia, Biphenotypic, Acute 7Primary Myelofibrosis 6Leukemia 6Recurrence 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Graft vs Host Disease 5Congenital Abnormalities 5Blast Crisis 5

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 35Peripheral Blood Stem Cell Transplantation 31dinutuximab 29Radiotherapy 29Granulocyte Colony-Stimulating Factor 29sargramostim 283-Iodobenzylguanidine 27Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16Ifosfamide 15naxitamab 14fludarabine phosphate 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neuroblastoma × Cyclosporins × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Nationwide Children's Hospital

Phase 2 Withdrawn
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡